Curcumin analogues exert potent inhibition on human and rat gonadal 3β-hydroxysteroid dehydrogenases as potential therapeutic agents: structure-activity relationship and in silico docking

References

• Lestari ML, Indrayanto G.  Curcumin. Profiles Drug Subst Excip Relat Methodol. 2014;39:113–204.
   PubMedGoogle Scholar
• Unlu A, Nayir E, Dogukan Kalenderoglu M, Kirca O, Ozdogan M. Curcumin (turmeric) and cancer. J BUON. 2016;21(5):1050–1060.
   PubMedGoogle Scholar
• Ammon HP, Wahl MA. Pharmacology of curcuma longa. Planta Med. 1991;57(1):1–7.
   PubMed Web of Science ®Google Scholar
• Xu S, Chen M, Chen W, Hui J, Ji J, Hu S, Zhou J, Wang Y, Liang G. Chemopreventive effect of chalcone derivative, l2h17, in colon cancer development. BMC Cancer. 2015;15:870.
   PubMed Web of Science ®Google Scholar
• Zeng C, Zhong P, Zhao Y, Kanchana K, Zhang Y, Khan ZA, Chakrabarti S, Wu L, Wang J, Liang G. Curcumin protects hearts from ffa-induced injury by activating nrf2 and inactivating nf-kappab both in vitro and in vivo. J Mol Cell Cardiol. 2015;79:1–12.
   PubMed Web of Science ®Google Scholar
• Shah V, Bhaliya J, Patel GM. In silico docking and adme study of deketene curcumin derivatives (dkc) as an aromatase inhibitor or antagonist to the estrogen-alpha positive receptor (eralpha(+)): Potent application of breast cancer. Struct Chem. 2022;33(2):571–600.
   PubMed Web of Science ®Google Scholar
• Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins i-iii from curcuma longa. Phytomedicine. 2000;7(4):303–308.
   PubMed Web of Science ®Google Scholar
• Mehner M, Kubelt C, Adamski V, Schmitt C, Synowitz M, Held-Feindt J. Combined treatment of at101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells. J Cancer Res Clin Oncol. 2020;146(1):117–126.
   PubMed Web of Science ®Google Scholar
• Simard J, Ricketts ML, Gingras S, Soucy P, Feltus FA, Melner MH. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr Rev. 2005;26(4):525–582.
   PubMed Web of Science ®Google Scholar
• Bolisetty S, Lui K, Oei J, Wojtulewicz J. A regional study of underlying congenital diseases in term neonates with necrotizing enterocolitis. Acta Paediatrica. 2007;89(10):1226–1230.
   Google Scholar
• Mellett Keith AM, Bruyette D, Stanley S. Trilostane therapy for treatment of spontaneous hyperadrenocorticism in cats: 15 cases (2004-2012). J Vet Intern Med. 2013;27(6):1471–1477.
   PubMed Web of Science ®Google Scholar
• de Carvalho GLC, Meirelles L, da Silva CC, Neto WS, Furtado PV, Machado L, de Moura Martins FS, da Silva Mello FP, de Faria Valle S, Pöppl ÁG. Assessment of selegiline and trilostane combined therapy efficacy for canine pituitary-dependent hypercortisolism treatment: A pilot randomized clinical trial. Res Vet Sci. 2022;150:107–114.
   PubMed Web of Science ®Google Scholar
• Hu GX, Lin H, Lian QQ, Zhou SH, Guo J, Zhou HY, Chu Y, Ge RS. Curcumin as a potent and selective inhibitor of 11beta-hydroxysteroid dehydrogenase 1: Improving lipid profiles in high-fat-diet-treated rats. PLoS One. 2013;8(3):e49976.
   PubMed Web of Science ®Google Scholar
• Hu GX, Liang G, Chu Y, Li X, Lian QQ, Lin H, He Y, Huang Y, Hardy DO, Ge RS. Curcumin derivatives inhibit testicular 17beta-hydroxysteroid dehydrogenase 3. Bioorg Med Chem Lett. 2010;20(8):2549–2551.
   PubMed Web of Science ®Google Scholar
• Tsutsumi R, Hiroi H, Momoeda M, Hosokawa Y, Nakazawa F, Koizumi M, Yano T, Tsutsumi O, Taketani Y. Inhibitory effects of cholesterol sulfate on progesterone production in human granulosa-like tumor cell line, kgn. Endocr J. 2008;55(3):575–581.
   PubMed Web of Science ®Google Scholar
• Cloix L, Reverchon M, Cornuau M, Froment P, Ramé C, Costa C, Froment G, Lecomte P, Chen W, Royère D, et al. Expression and regulation of intelectin1 in human granulosa-lutein cells: Role in igf-1-induced steroidogenesis through nampt. Biol Reprod. 2014;91(2):50. 2:
   PubMed Web of Science ®Google Scholar
• Xu RA, Mao B, Li S, Liu J, Li X, Li H, Su Y, Hu G, Lian QQ, Ge RS. Structure-activity relationships of phthalates in inhibition of human placental 3beta-hydroxysteroid dehydrogenase 1 and aromatase. Reprod Toxicol. 2016;61:151–161.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang B, Zhai Y, Tang Y, Lou Y, Zhu Y, Wang Y, Ge RS, Li H. Structure-activity relationship analysis of perfluoroalkyl carbonic acids on human and rat placental 3beta-hydroxysteroid dehydrogenase activity. Toxicology. 2022;480(:153334.
   PubMed Web of Science ®Google Scholar
• Zhao X, Ji M, Wen X, Chen D, Huang F, Guan X, Tian J, Xie J, Shao J, Wang J, et al. Effects of midazolam on the development of adult leydig cells from stem cells in vitro. Front Endocrinol (Lausanne)). 2021;12(:765251.
   PubMed Web of Science ®Google Scholar
• Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Zidek A, Potapenko A, et al. Highly accurate protein structure prediction with alphafold. Nature. 2021;596(7873):583–589.
   PubMed Web of Science ®Google Scholar
• Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, Yuan D, Stroe O, Wood G, Laydon A, et al. Alphafold protein structure database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50(D1):D439–D444.
   PubMed Web of Science ®Google Scholar
• Ongtanasup T, Wanmasae S, Srisang S, Manaspon C, Net-Anong S, Eawsakul K. In silico investigation of ace2 and the main protease of sars-cov-2 with phytochemicals from myristica fragrans (houtt.) for the discovery of a novel covid-19 drug. Saudi J Biol Sci. 2022;29(9):103389.
   PubMed Web of Science ®Google Scholar
• Ongtanasup T, Mazumder A, Dwivedi A, Eawsakul K. Homology modeling, molecular docking, molecular dynamic simulation, and drug-likeness of the modified alpha-mangostin against the beta-tubulin protein of acanthamoeba keratitis. Molecules. 2022;27(19):6338.
   PubMed Web of Science ®Google Scholar
• Wallace AC, Laskowski RA, Thornton JM. Ligplot: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 1995;8(2):127–134.
   PubMedGoogle Scholar
• Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, Schroeder M. Plip 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and rna. Nucleic Acids Res. 2021;49(W1):W530–W534.
   PubMed Web of Science ®Google Scholar
• Irwin JJ, Shoichet BK. Zinc–a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45(1):177–182.
   PubMed Web of Science ®Google Scholar
• Thomas JL, Mason JI, Brandt S, Spencer BR, Jr., Norris W. Structure/function relationships responsible for the kinetic differences between human type 1 and type 2 3beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity. J Biol Chem. 2002;277(45):42795–42801.
   PubMed Web of Science ®Google Scholar
• Sprous DG, Palmer RK, Swanson JT, Lawless M. Qsar in the pharmaceutical research setting: Qsar models for broad, large problems. Curr Top Med Chem. 2010;10(6):619–637.
   PubMed Web of Science ®Google Scholar
• Sang J, Chu J, Zhao X, Quan H, Ji Z, Wang S, Tang Y, Hu Z, Li H, Li L, et al. Curcuminoids inhibit human and rat placental 3beta-hydroxysteroid dehydrogenases: Structure-activity relationship and in silico docking analysis. J Ethnopharmacol. 2023;305:116051. 2022
   PubMed Web of Science ®Google Scholar
• Pandey A, Chaturvedi M, Mishra S, Kumar P, Somvanshi P, Chaturvedi R. Reductive metabolites of curcumin and their therapeutic effects. Heliyon. 2020;6(11):e05469.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm. 2007;4(6):807–818.
   PubMed Web of Science ®Google Scholar
• Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother. 2017;85:102–112.
   PubMed Web of Science ®Google Scholar
• Li R, Qiao X, Li Q, He R, Ye M, Xiang C, Lin X, Guo D. Metabolic and pharmacokinetic studies of curcumin, demethoxycurcumin and bisdemethoxycurcumin in mice tumor after intragastric administration of nanoparticle formulations by liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(26):2751–2758.
   PubMed Web of Science ®Google Scholar
• Jude S, Amalraj A, Kunnumakkara AB, Divya C, Loffler BM, Gopi S. Development of validated methods and quantification of curcuminoids and curcumin metabolites and their pharmacokinetic study of oral administration of complete natural turmeric formulation (cureit) in human plasma via uplc/esi-q-tof-ms spectrometry. Molecules. 2018;23(10):2415.
   PubMed Web of Science ®Google Scholar
• Thomas JL, Duax WL, Addlagatta A, Scaccia LA, Frizzell KA, Carloni SB. Serine 124 completes the tyr, lys and ser triad responsible for the catalysis of human type 1 3beta-hydroxysteroid dehydrogenase. J Mol Endocrinol. 2004;33(1):253–261.
   PubMed Web of Science ®Google Scholar
• Onoda N, Ishikawa T, Nishio K, Tahara H, Inaba M, Wakasa K, Sumi T, Yamazaki T, Shigematsu K, Hirakawa K. Cushing’s syndrome by left adrenocortical adenoma synchronously associated with primary aldosteronism by right adrenocortical adenoma: Report of a case. Endocr J. 2009;56(3):495–502.
   PubMed Web of Science ®Google Scholar
• Rege J, Hoxie J, Liu CJ, Cash MN, Luther JM, Gellert L, Turcu AF, Else T, Giordano TJ, Udager AM, et al. Targeted mutational analysis of cortisol-producing adenomas. J Clin Endocrinol Metab. 2022;107(2):e594–e603.
   PubMed Web of Science ®Google Scholar
• Bostan H, Duger H, Akhanli P, Calapkulu M, Turkmenoglu TT, Erdol AK, Duru SA, Sencar ME, Kizilgul M, Ucan B, et al. Cushing’s syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: A case report and literature review. Hormones (Athens). 2022;21(1):147–154.
   PubMedGoogle Scholar
• Czapla-Iskrzycka A, Świątkowska-Stodulska R, Sworczak K. Comorbidities in mild autonomous cortisol secretion - a clinical review of literature. Exp Clin Endocrinol Diabetes. 2022;130(09):567–576.
   PubMed Web of Science ®Google Scholar
• Allen LA, Shrikrishnapalasuriyar N, Rees DA. Long-term health outcomes in young women with polycystic ovary syndrome: A narrative review. Clin Endocrinol (Oxf)). 2022;97(2):187–198.
   PubMed Web of Science ®Google Scholar
• Igaz P, Tombol Z, Szabo PM, Liko I, Racz K. Steroid biosynthesis inhibitors in the therapy of hypercortisolism: Theory and practice. Curr Med Chem. 2008;15(26):2734–2747.
   PubMed Web of Science ®Google Scholar